Lifeboat Foundation

Yesterday, the Whitehouse announced that the USA and the EU (European Union) signed an administrative agreement to bring AI experts together to advance AI research as prior outlined in the U.S.-EU Trade and Technology Council (TTC) commitment.

This effort will further drive responsible advancements in AI to advance global complex challenges and develop a joint integrated research approach to achieve benefits in key research domains: extreme weather and climate forecasting, emergency response management, health and medicine, electric grid optimization, and agriculture optimization.

This article focuses on the AI leadership with the USA and the European Union in signing a new administrative agreement to do joint AI research in key global challenge areas like: climate change, healthcare, agriculture, etc.

Continue reading “USA And EU Advance AI Research In Critical Global Needs In New Administrative Agreement” »

But every once in a while, an idea is so powerful and so profound its effects are felt much faster.

That’s been the case with CRISPR gene editing, which celebrates a 10th anniversary this month. It has already had a substantial impact on laboratory science, improving precision and speeding research, and it has led to clinical trials for a handful of rare diseases and cancers.

Over the next decade, scientists predict, CRISPR will yield multiple approved medical treatments and be used to modify crops, making them more productive and resistant to disease and climate change.

Explore the cutting-edge technologies revolutionizing the world of agriculture. From self-driving tractors to robotic fruit pickers, learn how robotics and automation are improving crop yields, reducing labor costs, and making farming more sustainable. Discover the future of these technologies and how they are shaping the future of food production. This video is a must-watch for anyone interested in the intersection of technology and agriculture.

What are your thoughts on the future of robotics and automation in agriculture? Let us know!
Any disruptive technologies you would like us to cover? Dm us on our Instagram (@toyvirtualstructures).
—————–
Check out our curated playlists:
https://www.youtube.com/channel/UCr5Akn6LhGDin7coWM7dfUg/playlists.
—————–
Media Used:
Smart Orchard.
Precision Hawk.
OECD
Cambridge Consultants.
—————–
Want more content?
Check us out at:
Instagram: @toyvirtualstructures.
Twitter: @web3tvs

See AI describe in text and dozens of pictures the many ways it could wipe us out. See the power of Open AI’s ChatGPT and Stable Platform text to chat and text to art. Does this resemble some of the things already afoot by human characters today? What can we do about it?

Save 1% on GoldBacks from Galactic Greg’s affiliate link (Use coupon code GreenGregs):
https://www.defythegrid.com/goldbacks/ref/30/

Continue reading “Ai Tells & Shows How it Will Wipe us Out” »

A device developed at the University of Florida for the U.S. military provides protection from mosquitos for an extended period and requires no heat, electricity or skin contact.

The controlled-release passive device was designed by Nagarajan Rajagopal, a Ph.D. candidate and Dr. Christopher Batich in UF’s Department of Materials Science and Engineering in the Herbert Wertheim College of Engineering. It recently was tested successfully in a four-week semi-field study at the U.S. Department of Agriculture in Gainesville in a collaboration with Dr. Daniel Kline, Dr. Jerry Hogsette and Adam Bowman from the USDA’s Center for Medical, Agricultural and Veterinary Entomology.

Results showed the controlled release of the repellent transfluthrin was effective in preventing multiple species of mosquitos from entering the testing site. Transfluthrin is an organic insecticide considered to be safe for humans and animals.

According to the U.S. Centers for Disease Control and Prevention, more than 40% of people living in the U.S. are obese; and 43% of American women over the age of 60—long past menopause—are considered obese. A recent Johns Hopkins study showed that a drug first developed to treat Alzheimer’s disease, schizophrenia, and sickle cell disease could treat obesity and fatty liver and improve heart function—without changes in food intake or daily activity.

The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically help us live longer and keep us healthier in our latter years.

Rilmenidine was picked for this latest study because past research has shown it mimics the effects of caloric restriction on a cellular level. Reducing available energy while maintaining nutrition within the body has been shown to extend lifespans in several animal models.

Whether this translates to human biology, or is a potential risk to our health, is a topic of ongoing debate. Finding ways to achieve the same benefits without the costs of extreme calorie cutting could lead to new ways to improve health in old age.

Mistletoe may be a welcome holiday sight when hung over a doorway if a loved one is near. But it can be an unwelcome intruder when found in your trees, according to a Texas A&M AgriLife Extension Service horticulturist.

“Mistletoe is a hemiparasite—a semi-parasitic plant,” said Allison Watkins, AgriLife Extension horticulturist for Tom Green County. “It makes its food from photosynthesis, but the roots grow into the host tree, sucking water and minerals out from the sap.”

In other words, you likely do not want to see mistletoe growing on your favorite shade tree or prized ornamental. However, mistletoe can survive as long as the tree it inhabits. So, some mistletoe alive today may still be around in 100 years.

You’ve seen the headlines. The FDA approved its use in tackling the underlying genetic mutation for sickle cell disease. Some researchers edited immune cells to fight untreatable blood cancers in children. Others took pig-to-human organ transplants from dream to reality in an attempt to alleviate the shortage of donor organs. Recent work aims to help millions of people with high cholesterol—and potentially bring CRISPR-based gene therapy to the masses—by lowering their chances of heart disease with a single injection.

But to Dr. Jennifer Doudna, who won the Nobel Prize in 2020 for her role in developing CRISPR, we’re just scratching the surface of its potential. Together with graduate student Joy Wang, Doudna laid out a roadmap for the technology’s next decade in an article in Science.

If the 2010s were focused on establishing the CRISPR toolbox and proving its effectiveness, this decade is when the technology reaches its full potential. From CRISPR-based therapies and large-scale screens for disease diagnostics to engineering high-yield crops and nutritious foods, the technology “and its potential impact are still in their early stages,” the authors wrote.